Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Literature
1.
2.
Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan AV (2020) Hyperinflammatory syndrome in children associated with COVID-19: need for awareness. Indian Pediatr 57:929–935CrossRef
3.
Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, De Nisco A, Angelone DF, Compagnone A, Delogu AB (2010) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30:841–846CrossRef
4.
Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S (2016) Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int J Mol Sci 17:278CrossRef
5.
Rigante D (2020) Kawasaki disease as the immune-mediated echo of a viral infection. Mediterr J Hematol Infect Dis 12:e2020039CrossRef
Metadata
Title
Telemedicine and the risk of overshadowing children with Kawasaki disease in a worldwide coronavirus pandemic climate
Author
Donato Rigante
Publication date
01-10-2021
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 7/2021
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02662-7

Other articles of this Issue 7/2021

Internal and Emergency Medicine 7/2021 Go to the issue

CE - LETTER TO THE EDITOR

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment

CE-Research Letter to the Editor

Interns’ anticipatory anxiety about cardiopulmonary resuscitation: reducing it while bolstering confidence with psychological skills training

IM - ORIGINAL

High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study

IM - ORIGINAL

A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol

CE - LETTER TO THE EDITOR

Medical wards, the worst of the class for “never events”: considerations and actions

IM - REVIEW

The everchanging framework of autoinflammation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits